Frankfurt
28.08.26 | 21:40
0,155 Euro
-3,73 % -0,006
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.08. | Vext Science reports Q2 results | 1 | Seeking Alpha | ||
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 20.08. | VEXT Science, Inc.: Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter | 608 | Newsfile | Revenue of $12.1 million, level with Q1 2026, as Ohio growth offset the planned Arizona cultivation wind-down.Adjusted EBITDA* of $3.4 million, up 22% from Q1 2026; net loss narrowed 79% year-over-year... ► Artikel lesen | |
| 13.08. | Vext Science Inc: Vext Science to release Q2 results on Aug. 20 | 1 | Stockwatch | ||
| 12.08. | VEXT Science, Inc.: Vext Announces Date for Q2 2026 Financial Results Release | 625 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 12, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today... ► Artikel lesen | |
| 02.06. | VEXT Science, Inc.: Vext Opens Sixth Ohio Dispensary in Fairfield | 522 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with operations in Arizona... ► Artikel lesen | |
| 21.05. | Vext Science reports Q1 results | 5 | Seeking Alpha | ||
| 21.05. | VEXT Science, Inc.: Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales | 848 | Newsfile | Revenue of $12.2 million, up 5.2% year-over-year; gross profit more than doubled to $5.5 million (45.4% margin), and net loss narrowed 73.2% to $(0.9) million.Operating cash flow of $1.6 million... ► Artikel lesen | |
| 15.05. | Vext Science Inc: Vext Science hires Zuanic & Associates for IR | 2 | Stockwatch | ||
| 15.05. | VEXT Science, Inc.: Vext Engages Zuanic & Associates | 560 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with operations in Arizona and... ► Artikel lesen | |
| 14.05. | VEXT Science, Inc.: Vext Announces Date for Q1 2026 Financial Results Release | 663 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced... ► Artikel lesen | |
| 30.04. | Vext Science reports Q4 results | 1 | Seeking Alpha | ||
| 29.04. | VEXT Science, Inc.: Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales | 385 | Newsfile | Fiscal 2025 revenue of $51.4 million, up +43% YoY, with EBITDA* of $5 million and Adjusted EBITDA* of $10.9 million; net cash provided by operating activities of $11.7 million, up +256% (+$8.4 million)... ► Artikel lesen | |
| 22.04. | Vext Science Inc: Vext revises 2025 results release date to April 29 | 1 | Stockwatch | ||
| 21.04. | VEXT Science, Inc.: Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release | 444 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today... ► Artikel lesen | |
| 30.03. | Vext Science Inc: Vext to discontinue operations at Arizona facility | 1 | Stockwatch | ||
| 30.03. | VEXT Science, Inc.: Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion | 1.797 | Newsfile | Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow.Proceeds from the sale to facilitate debt reduction, with key... ► Artikel lesen | |
| 04.03. | Vext Science Inc: Vext receives licence for seventh dispensary in Ohio | 4 | Stockwatch | ||
| 03.03. | VEXT Science, Inc.: Vext Advances Ohio Expansion with Seventh Retail Location | 507 | Newsfile | Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals.Marks Vext's seventh dispensary in Ohio, and second in... ► Artikel lesen | |
| 11.12.25 | VEXT Science, Inc.: Vext Announces Voting Results of Annual General Meeting | 538 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
| 20.11.25 | VEXT Science, Inc.: Vext Reports Q3 2025 Financial Results | 1.290 | Newsfile | Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,454 | -0,12 % | Aurora Cannabis: Was Curaleaf jetzt wirklich plant | ||
| CANOPY GROWTH | 0,866 | +1,05 % | Canopy Growth Corporation: Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows | Renewed certification maintains Kincardine's role in Canopy Growth's EU GMP flower supply chain
Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX: WEED) (Nasdaq: CGC)... ► Artikel lesen | |
| TILRAY BRANDS | 3,980 | +0,51 % | Tilray Brands, Inc.: BrewDog triumphiert bei den World Beer Awards 2026 mit herausragender Braukunst | Hazy Jane, Wingman und Mackie's Two Scoops werden mit Goldmedaillen und dem Scotland Country Winner Award ausgezeichnet. Zu den besten Bieren der Welt zählen auch Punk IPA, Lost Lager, Black Heart und... ► Artikel lesen | |
| INNOCAN PHARMA | 1,430 | -2,39 % | InnoCan Pharma: Strategische Neuausrichtung mit Fokus auf Wachstum | ||
| CRONOS GROUP | 2,842 | -2,40 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 0,621 | +0,16 % | Portfolio unwound; rating placed Under Review: Wave of portfolio insolvencies narrows SYNBIOTIC to WEECO ... | SYNBIOTIC's investment case has changed fundamentally after a wave of insolvencies and liquidations across the portfolio. What began with the Bushdoctor (Austria) insolvency in December 2025 has widened... ► Artikel lesen | |
| DIGICANN VENTURES | 0,007 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,026 | 0,00 % | Organigram Global Inc.: Organigram Global treibt die Integration der Sanity Group unter einer einheitlichen globalen Betriebsstruktur voran | Führung, operatives Geschäft und Marktentwicklung werden über eine globale Plattform aufeinander abgestimmt, die Kanada mit Deutschland und anderen wichtigen internationalen Märkten verbindet
Die... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,700 | +2,45 % | The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up. | ||
| SNDL | 1,144 | -2,22 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| CRESCO LABS | 0,626 | -6,29 % | Cresco Labs Q2 2026 slides: cannabis re-rating thesis meets skepticism | ||
| NOVERIS HEALTH SCIENCES | 0,100 | -14,53 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000 | Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") is pleased to announce its intention... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,584 | 0,00 % | Quantum Biopharma Provides Corporate Update | THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 21, 2026... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 1,000 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly Food Group Reports Record Results of $28.4M in Q2 System Wide QSR Sales with Year Over Year Growth of 75% | Toronto, Ontario--(Newsfile Corp. - August 26, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| COMPASS PATHWAYS | 12,000 | +0,84 % | Zwei Wege zur Psychedelika-Therapie: Emyrias Klinikmodell im Vergleich zum FDA-Zulassungsrennen von Compass Pathways |
VEXT SCIENCE INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -3,73 % bei einem Aktienkurs von 0,155 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.